Current Estimates of Supply and Utilization of Immune Globulin Products

In February 2007, the Eastern Research Group (ERG) submitted to the Office of the Assistant Secretary for Planning and Evaluation (ASPE) Analysis of Supply, Distribution, Demand, and Access Issues Associated with Immune Globulin Intravenous (IGIV) (2007 report).  This report examined IGIV market dynamics and the potential health consequences of IGIV access problems.  ASPE initiated the research in response to concerns from patients and physicians about difficulties in acquiring IGIV, switching from administration in physician offices to hospital outpatient facilities, and switching between IGIV products.  This ASPE research brief updates figures and tables from the 2007 report with recent data on supply and distribution and demand and utilization of Immune Globulin (IG) products.